VickySanzMoreno
banner
vickysanzmoreno.bsky.social
VickySanzMoreno
@vickysanzmoreno.bsky.social
Professor of Cancer Cell and Metastasis Biology. CRUK Senior Fellow. Institute of Cancer Research. London.
https://www.icr.ac.uk/our-research/researchers-and-groups/professor-victoria-sanz-moreno
We are very happy to welcome Yifei Zhang, as a new lab member to the Cytoskeleton and Metastasis Team.
Yifei will be studying transcriptional and cytoskeletal dynamics in invasive lobular carcinoma (ILC).
@icr.ac.uk
December 8, 2025 at 8:38 AM
Delighted to have been elected a Fellow of the European Academy of Cancer Sciences alongside some outstanding colleagues!
www.europeancanceracademy.eu/news/new-eac...
New EACS Fellows 2025 | European Academy of Cancer Sciences
www.europeancanceracademy.eu
November 29, 2025 at 11:47 AM
Applications now open for CRUK Clinical Academic PhD Training Programme. Join us @icr.ac.uk and The Royal Marsden NHS Foundation Trust.
We are offering a super exciting project to investigate cytoskeletal dynamics in Circulating Tumour Cells from Breast Cancer Patients.
November 17, 2025 at 1:02 PM
Reposted by VickySanzMoreno
Heads up! Small change to Friday’s workshop: Dr. Sebastian Carotta can’t make it, but we’re thrilled to have Dr. Victoria Sanz-Moreno (ICR) stepping in to talk about “Biomechanical hallmarks & vulnerabilities of metastatic & therapy resistant cancer cells” See you there! @vickysanzmoreno.bsky.social
November 12, 2025 at 8:20 AM
Sad to see three of our beloved lab members leaving us! Yumiko Teigen, Paramita Kundu and Jaume Barcelo- We wish you the best of luck for your future endeavours!
@icr.ac.uk
November 5, 2025 at 9:11 AM
Reposted by VickySanzMoreno
Early stages of #metastasis are poorly understood despite causing 90% of cancer deaths. A new project led by Prof Darryl Overby and Prof @vickysanzmoreno.bsky.social is looking to develop tools to study #cancer spread in unprecedented detail while reducing the need for animals in research.🐁👇
Congratulations to our 2025 Development Fund awardees! 🎉

From new detection tools to targeted nanotech therapies, these seed funded projects explore bold ideas to improve cancer diagnosis & treatment.
👉 bit.ly/4gV38tf

@icr.ac.uk @imperialcollegeldn.bsky.social @imperialsandc.bsky.social
October 10, 2025 at 10:08 AM
We are offering a super exciting project to develop new ways of targeting metastatic cancer cells!
Amazing supervisory team:
Primary supervisor: Professor Joanna Loizou
Associate supervisor: Professor Zoran Rankovic
Secondary supervisor: Professor Victoria Sanz-Moreno
@icr.ac.uk
Targeting AMPK as a metabolic vulnerability of metastatic cancer cells
Targeting AMPK as a metabolic vulnerability of metastatic cancer cells
www.icr.ac.uk
October 9, 2025 at 6:19 PM
We are so happy to welcome @dorioliveri.bsky.social as a new lab member to the Cytoskeleton and Metastasis Team. Doriana will study how the extracellular matrix in different metastatic sites regulates tumour-immune cell interactions😀
ADAPTMET
@icr.ac.uk
@breastcancernow.bsky.social
October 9, 2025 at 12:33 PM
Reposted by VickySanzMoreno
The stage is set! @vickysanzmoreno.bsky.social is kicking off their keynote at #cellmech2025.
October 1, 2025 at 11:49 AM
CellMech2025!! Exciting!
September 30, 2025 at 12:15 PM
Congratulations to Yumiko Teigen who had her PhD viva yesterday! She did such a fantastic job! Thanks to the examiners for their insightful comments
@cancerresearchuk.org @breastcancernow.bsky.social @icr.ac.uk @qmbci.bsky.social 😍
July 18, 2025 at 11:22 AM
Reposted by VickySanzMoreno
Really exciting to see these results from our Curestarter researchers - thanks for sharing @vickysanzmoreno.bsky.social!
July 16, 2025 at 9:44 AM
Congratulations to Samantha George in the lab for receiving the Best Talk Prize at "The Diversity in Immunology Meeting" by @britsocimm.bsky.social for her beautiful work on tumour-associated macrophages. We are very proud of you Sam! 🤩
July 15, 2025 at 1:29 PM
🚨 New publication alert! Excited to share our latest work
SLC7A11 protects amoeboid-disseminating cancer cells from oxidative stress: Cell Reports www.cell.com/cell-reports...
SLC7A11 protects amoeboid-disseminating cancer cells from oxidative stress
Graziani et al. show that SLC7A11 increases during melanoma disease progression. SLC7A11 promotes Myosin II-driven amoeboid invasive behavior while shielding amoeboid cancer cells from oxidative stres...
www.cell.com
July 11, 2025 at 4:53 PM
Reposted by VickySanzMoreno
The results, published in @cp-cellreports.bsky.social could lead to new tests to spot the most aggressive cancers, and treatments to stop them spreading.

“If we take away the melanoma cells’ shield and armour, we could stop cancer in its tracks.’
- Lead researcher Prof @vickysanzmoreno.bsky.social
July 11, 2025 at 3:03 PM
Reposted by VickySanzMoreno
BREAKING 📰

A ‘suit of armour’ protein could be targeted to stop aggressive #Melanoma from spreading.

ICR scientists have discovered that SLC7A11 protects the most aggressive melanoma cancer cells from damage as they pass through stressful environments.

More here ⤵️
www.icr.ac.uk/about-us/icr...
July 11, 2025 at 3:03 PM
I am happy to be shortlisted in the Life Sciences category of the #GlobalCall25. This recognition brings
me a step closer to the Science Breakthroughs of the Year, to be celebrated at the #FallingWalls
#ScienceSummit25 from 6-9 November.
More info: falling-walls.com/science-summ... @FallingWalls
June 30, 2025 at 1:29 PM
Reposted by VickySanzMoreno
A huge thank you to all the amazing delegates who joined us for Small G Proteins in Cellular Signalling and Disease 2025 this week! We hope you enjoyed the conference and look forward to seeing you at the next one. #BiochemEvent #SGP25 🧪
June 27, 2025 at 12:44 PM
Reposted by VickySanzMoreno
Last day of the #SmallGproteins meeting, great evening last night meeting researchers in the field hearing about people’s journeys, and gave advice on expressing a phosphorylated GTPase.

Looking forward to Session 6 kicked off by @vickysanzmoreno.bsky.social!

@biochemsoc.bsky.social #BiochemEvent
June 27, 2025 at 7:44 AM
Reposted by VickySanzMoreno
Excited to be selected as one of the Social Media Contributors at the #BiochemEvent Small G Proteins Meeting next week, thanks to @biochemsoc.bsky.social.
I look forward to hearing about and discussing the latest research in the area as well as presenting my own PhD work about Arf proteins!
June 18, 2025 at 12:50 PM
Reposted by VickySanzMoreno
The Company of Biologists Workshop - Mechanometabolism Unleashed: The Interface of Cell Mechanics and Metabolism

Thank you to Workshop organisers Marco Foiani, Ana-Maria Lennon-Duménil, Victoria Sanz-Moreno and Giorgio Scita.

#Workshop #Biology #CellBiology #Community #Collaboration #Research
June 26, 2025 at 8:57 AM
Reposted by VickySanzMoreno
We are delighted to host @vickysanzmoreno.bsky.social today from the @icr.ac.uk!

"Biomechanical hallmarks and vulnerabilities of metastatic cancer cells"

📍 Alfred Denny Conference Room
📅 4th June - 1pm

@insigneoinstitute.bsky.social
@sheffielduni.bsky.social
@sheffielduni.bsky.social
June 4, 2025 at 7:25 AM
Very proud of former PhD student Yaiza Jung who has received the #BACR Chris Marshall Prize for Cell Signalling 😍!
it was such a pleasure to co-supervise her PhD with @jezcarlton.bsky.social 😀
June 3, 2025 at 4:49 PM
Reposted by VickySanzMoreno
Immunotherapy can help people with advanced head and neck cancer live years longer without their disease growing or coming back. It's the biggest improvement in treating this cancer type for decades.

Find out more: news.cancerresearchuk.org/2025/05/31/asc
ASCO 2025: head and neck cancer immunotherapy and targeted drugs for breast cancer improve outcomes - Cancer Research UK - Cancer News
Our experts are helping us sort through the cancer studies at ASCO, the world's biggest cancer conference.
news.cancerresearchuk.org
May 31, 2025 at 4:19 PM
Reposted by VickySanzMoreno
BREAKING 📰

A powerful new drug for advanced #BreastCancer can be used to treat emerging tumours, months before they have a chance to grow, keeping patients well for longer, according to new research shared today at @ascocancer.bsky.social

Professor Nick Turner shares his findings ⬇️

#ASCO25
June 1, 2025 at 12:02 PM